• Opioid Dependence
  • 5-AMP-Activated Protein Kinase, Gamma-2 Subunit (PRKAG2) Mutation Analysis
  • Culture, Genital
  • Direct Antiglobulin (Direct Coombs) Test
  • UBE3A Gene Mutation Analysis, Angelman Syndrome, Blood
  • Vitamin A
  • Hepatic steatosis (fatty liver)
  • NOP10 Gene Mutation Analysis
  • Flunitrazepam, Urine
  • Methylmalonic Acid (MMA), Quantitative, Serum
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /OncoExTra (Oncomap™ ExTra) for Metastatic Cancer
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

OncoExTra (Oncomap™ ExTra) for Metastatic Cancer
Medical Test

Clinical Utility
Access to OncoExTra (Oncomap™ ExTra) for Metastatic Cancer is restricted.